Résumé
La remise en valeur des atteintes veineuses dans la sclérose en plaques (SEP) par la théorie de l’insuffisance veineuse cérébro- spinale (CCSVI) a fait naître un espoir immense parmi tous les patients atteints, relayé par les forums du Net, espoir souvent déçu à l’origine de comportements inadaptés, difficiles à maîtriser. Elle a entraîné une multiplication des actes interventionnels par des opérateurs inexpérimentés en pathologie veineuse, attirés par la fréquence de cette maladie. Des établissements centrés sur la prise en charge diagnostique et thérapeutique des atteintes veineuses dans la SEP ont vu le jour, appuyés par des publicités spectaculaires via Internet.
Preview
Unable to display preview. Download preview PDF.
Références
Frohman EM, Racke MK, Raine CS (2006) Multiple sclerosis — the plaque and its pathogenesis. N Engl J Med 354: 942–55
De Jager PL, Jia X, Wang J et al. (2009) Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet 41: 776–82
Ascherio A, Munger K (2007) Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol. 61: 288–99
Ascherio A, Munger KL (2007) Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann Neurol. 61: 504–13
Jones JL, Coles AJ (2010) New treatment strategies in multiple sclerosis. Exp Neurol 225: 34–39
Charcot (1868) Histologie de la sclérose en plaques. Gaz Hopit Civils Milit. 41: 554–566
Rindfleisch (1863). Histologisches detail zu der grauen degeneration von gehirn und rueckenmark. Arch. Path. Anat. Physiol. Klin. Med. 26: 474
Putnam TJ (1937) Lesions of “Encephalomyelitis” and Multiple Sclerosis: Venous Thrombosis as the Primary Alteration, J. A. M. A. 108:1477–1480
Losy J, Niezgoda A, Wender MJ (1999) Increased serum levels of soluble PECAM-1 i multiple sclerosis patients with brain gadolinium-enhancing lesions Neuroimmunol. 99: 169–72
Minagar A, Jy W, Jimenez JJ, Alexander JS (2006) Neurol Res. 2006 Multiple sclerosis as a vascular disease Neurol Res. 28: 230–5
Fainardi E, Castellazzi M, Bellini T et al. (2006) Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis. Multiple Sclerosis 12: 294–301
Adams CW, Poston RN, Buk SJ (1989) Pathology, histochemistry and immunocytochemistry of lesions in acute multiple sclerosis. J Neurol Sci 92: 291–306
Adams CW (1988) Perivascular iron deposition and other vascular damage in multiple sclerosis. J Neurol Neurosurg Psychiatry 51: 260–5
Fog T (1965) The topography of plaques in multiple sclerosis with special reference to cerebral plaques. Acta Neurol Scand Suppl 15: 1–161
Schelling F (1986) Damaging venous reflux into the skull or spine: relevance to multiple sclerosis. Med Hypotheses 21: 141–148
Kermode AG, Thompson AJ, Tofts P et al. (1990) Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenic and clinical implications. Brain 113: 1477–89
Kwon EE, Prineas JW (1994) Blood-brain barrier abnormalities in longstanding multiple sclerosis lesions. An immunohistochemical study. J Neuropathol Exp Neurol. 53: 625–36
Zamboni P (2006) The big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis. J R Soc Med. 99: 589–93
Zamboni P, Menegatti E, Galeotti R et al. (2009) The value of cerebral Doppler venous haemodynamics in the assessment of multiple sclerosis. J Neurol Sci. 282(1-2): 21–7
Zamboni P, Galeotti R, Menegatti E et al. (2009) Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry. 80: 392–9
San Millan Ruiz, D, Gailloud P, Rufenacht DA et al. (2002). The craniocervical venous system in relation to cerebral venous drainage. AJNR Am. J. Neuroradiol 23: 1500–08
Braun JP, Tournade A (1977). Venous drainage in the craniocervical region. Neuroradiology 13: 155–58
Ibukuro K, Fukuda H, Mori, K et Inoue Y (2001). Topographic anatomy of the vertebral venous system in the thoracic inlet. AJR Am. J. Roentgenol 176: 1059–65
Silva MA, Deen KI, Fernando DJ, Sheriffdeen A H (2002). The internal jugular vein valve may have a significant role in the prevention of venous reflux: evidence from live and cadaveric human subjects. Clin. Physiol. Funct. Imaging 22: 202–5
Chou CH, Chao AC, et Hu H (2002). Ultrasonographic evaluation of vertebral venous valves. AJNR Am. J. Neuroradiol 23: 1418–20
Valdueza JM, von Munster T, Hoffman O et al. (2000). Postural dependency of the cerebral venous outflow. Lancet 355: 200–1
Simka M, Kostecki J, Zaniewski M et al. (2010) Extracranial Doppler sonographic criteria of chronic cerebrospinal venous insufficiency in the patients with multiple sclerosis. Int Angiol. 29: 109–14
Zivadinov R, Marr K, Cutter G et al. (2011) Combined transcranial et extracranial venous Doppler evaluation (CTEVD) study. Description of the design and interim results of an epidemiological study of the prevalence of chronic cerebrospinal venous insufficiency in MS and related diseases. Neurology in press.
Doepp F, Paul F, Valdueza JM et al. (2010) No cerebrocervical venous congestion in patients with multiple sclerosis. Ann Neurol. 68: 173–83
Mayer CA, Pfeilschifter W, Lorenz MW et al. (2011) The perfect crime? CCSVI not leaving a trace in MS J Neurol Neurosurg Psychiatry. 82: 436–40
Baracchini C, Perini P, Calabrese M et al. (2011) No evidence of chronic cerebrospinal venous insufficiency at multiple sclerosis onset. Ann Neurol. 69: 90–9
Sundström P, Wåhlin A, Ambarki K et al. (2010) Venous and cerebrospinal fluid flow in multiple sclerosis: a case-control study. Ann Neurol. 68: 255–9
Zamboni P. (2010) Regarding “no cerebrocervical venous congestion in patients with multiple sclerosis. Intraluminal jugular septation”. Ann Neurol. 68: 969
Zivadinov R, Ramanathan M, Dwyer MG et al. (2011) Comment on “no evidence of chronic cerebrospinal venous insufficiency at multiple sclerosis onset”. Ann Neurol. 69: 1062–3
Zivadinov R, Galeotti R, Hojnacki D et al. (2011) Value of MR venography for detection of internal jugular vein anomalies in multiple sclerosis: a pilot longitudinal study. AJNR Am J Neuroradiol. 2011 May; 32: 938–46
Zamboni P, Menegatti E, Weinstock-Guttman B, Zivadinov R et al. (2009) The severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis is Funct Neurol. 24: 133–8
Poloni G, Minagar A, Haacke EM, Zivadinov R (2011). Recent developments in imaging of multiple sclerosis. Neurologist. 17: 185–204
Lejars F (1888) Les voies de sûreté de la veine rénale. Bull Soc Anat (Paris) 63e année 5e série; 504–11
Gillot C, Aaron C (1968) les voies de dérivation de la veine rénale gauche. Arch Anat pathol 16: 196–202
Kaplan HA, Browder A, Browder J (1973) Norrow and atretic transverse dural sinuses: clinical significance. Ann Otol Rhinol Laringol 82: 351–54
Zamboni P, Galeotti R, Menegatti E et al. (2009) A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency. J Vasc Surg. 50:n1348–58
Ludyga T, Kazibudzki M, Simka M et al. (2010) Endovascular treatment for chronic cerebrospinal venous insufficiency: is the procedure safe? Phlebology 25: 286–95
Petrov I, Grozdinski L, Kaninski GJ et al. (2011) Safety profile of endovascular treatment for chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. Endovasc Ther 18: 314–23
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag France, Paris
About this chapter
Cite this chapter
Greiner, M. (2013). Traitement endovasculaire et sclérose en plaques. In: Thérapeutiques endovasculaires des pathologies veineuses. Springer, Paris. https://doi.org/10.1007/978-2-8178-0291-6_10
Download citation
DOI: https://doi.org/10.1007/978-2-8178-0291-6_10
Publisher Name: Springer, Paris
Print ISBN: 978-2-8178-0290-9
Online ISBN: 978-2-8178-0291-6
eBook Packages: MedicineMedicine (R0)